Cross‑border M&A in Germany 2026: Procedure, Merger Control & Foreign Investment Screening

Cross-border m and a germany transactions in 2026 sit at the intersection of three distinct regulatory regimes, merger control under the Act against Restraints of Competition (GWB), foreign investment screening under the Foreign Trade and Payments Act (AWG) and its implementing ordinance (AWV), and takeover law under the Securities Acquisition and Takeover Act (WpÜG). For acquirers, sellers and private equity sponsors, the practical challenge is no longer identifying whether a review applies but sequencing parallel clearances without derailing the timetable. This guide maps the full procedural path, from pre‑deal triage through clearance to closing, with explicit timelines, required documents, costs and the 2026 developments that materially affect deal risk.

It is written for decision‑stage readers who need to know when to notify, how long reviews take, and where the common failure points lie.

If you are scoping a transaction now, speak to a specialist via the Cross‑Border Corporate practice, Germany page or the GLE lawyer directory, Cross‑Border Corporate lawyers in Germany before committing to a timetable.

Overview, what counts as a cross‑border M&A in Germany?

A cross‑border m and a germany deal is any acquisition, merger, joint venture or minority investment where at least one party is non‑German or where the target has operations, turnover or assets that engage German or EU regulatory jurisdiction. The structure chosen, share deal or asset deal, inbound or outbound, listed or private target, shapes which regimes apply and how the timetable is built.

Types of transactions covered

• Share deals. Acquisition of equity in a German target, the most common structure and the one most likely to trigger all three regimes.
• Asset deals. Purchase of a business, plant or asset portfolio; can still constitute a notifiable concentration and may engage AWV sector rules.
• Inbound vs outbound. Inbound investment into Germany drives AWV screening; outbound deals by German acquirers primarily raise merger control and foreign regimes abroad.
• Listed vs private targets. A listed German target adds WpÜG takeover and BaFin disclosure obligations on top of merger control and FDI review.

Primary regulatory risks

Three regulatory risks dominate cross‑border m and a germany planning. First, merger control: if GWB or EU turnover thresholds are met, the transaction cannot be implemented until cleared, a standstill obligation that can delay closing by one to four months or longer. Second, foreign investment screening under the AWG/AWV: inbound acquisitions touching critical infrastructure, defence, dual‑use goods, health, IT or telecoms may require notification to the competent federal ministry (currently the Federal Ministry for Economic Affairs and Energy, BMWE), with power to prohibit or impose protective conditions. Third, for listed targets, WpÜG takeover rules can trigger mandatory offer duties and strict disclosure and tender mechanics supervised by BaFin.

A three‑point decision checklist at the outset, merger control thresholds, FDI sector exposure, and WpÜG shareholding triggers, determines the entire deal architecture.

Eligibility, when will German merger control, AWV/foreign trade law or WpÜG apply?

Eligibility turns on three independent tests. Each must be run separately; satisfying one does not exclude the others, and a single transaction can engage all three regimes simultaneously.

Merger control thresholds (GWB & EU)

Under the GWB, a concentration is notifiable to the Bundeskartellamt when the parties’ combined and individual turnover thresholds are met, with national nexus requirements focusing review on deals with German market effect. Where the larger EU Merger Regulation turnover thresholds are met, the European Commission takes exclusive jurisdiction under the one‑stop‑shop principle, and no separate German filing is required. Running the turnover calculation early, by product and region, is essential to decide whether you file in Bonn (the Bundeskartellamt’s seat), Brussels, or both for carve‑out scenarios. Consult the GWB text on Gesetze im Internet and Bundeskartellamt guidance for the current consolidated thresholds.

FDI / AWV triggers and scope

The AWV distinguishes a cross‑sector screening regime and a stricter sector‑specific regime. Notification is mandatory where a non‑EU/non‑EFTA (and, for defence and certain sensitive security cases, any foreign) investor acquires voting rights at or above the statutory thresholds in a German target active in sensitive areas, critical infrastructure, defence and dual‑use goods, certain IT and telecommunications technologies, health and other listed sectors. Where a sector‑specific trigger applies, the transaction may not be completed before clearance (or before the review period lapses without objection). The relevant AWG and AWV provisions are published on Gesetze im Internet, with sector lists and thresholds maintained by the competent federal ministry.

Takeover / WpÜG triggers for public companies

For a listed German target, the WpÜG governs public bids. Crossing the statutory control threshold in voting rights triggers a mandatory offer obligation, requiring the acquirer to make an offer to all remaining shareholders at a regulated minimum price. BaFin supervises the offer document, timetable and disclosures. The WpÜG provisions are set out on Gesetze im Internet; coordinate any public announcement with BaFin and exchange rules from the outset.

Step‑by‑step cross‑border m and a germany process

The following ordered process is the operational core of any cross-border m and a germany transaction. Each step identifies who leads, the typical duration, the key filings and documents, and the tactical options. Treat it as a sequence to be compressed where possible through parallel working, but never at the expense of the standstill obligations described below.

1. Pre‑deal screening and risk assessment. Led by the acquirer’s in‑house counsel with external M&A counsel, this first step triages all three regimes before significant spend. Run the GWB and EU turnover calculation to test merger control notifiability; map the target’s activities against the AWV sector lists to test FDI exposure; and, for listed targets, check current and prospective shareholding against WpÜG thresholds. The output is a regulatory risk memorandum that drives the deal structure and timetable. For cross-border m and a germany deals, this triage also flags whether parallel filings will be needed and whether a long‑stop date must accommodate Phase II or an extended ministry review. Allow 1–2 weeks.
2. Structuring to minimise screening friction. The deal structure can reduce, though rarely eliminate, regulatory friction. Carve‑outs that exclude sensitive German assets from the acquisition perimeter may remove an AWV sector trigger; holding‑company structures and staged acquisitions can manage turnover aggregation and voting‑right thresholds. Each option carries regulatory pitfalls: artificial fragmentation designed solely to avoid notification risks challenge, and staged acquisitions may still be assessed as a single concentration. Involve tax counsel early, because structuring for screening and structuring for tax can pull in opposite directions. Allow 1–3 weeks.
3. Data room due diligence and preparation of merger control / AWV materials. The deal team, external counsel, antitrust counsel and an export‑control advisor should build the data room with filings in mind. Compile turnover data by product and region, market‑definition analysis, organisational charts, investor ownership and ultimate beneficial owner (UBO) diagrams, and a security‑impact assessment for any AWV‑relevant activity. Preparing these materials during due diligence rather than after signing shortens the gap between signing and notification. Allow 4–8 weeks.
4. Pre‑notification meetings and informal contacts with authorities. Informal pre‑notification contact with the Bundeskartellamt, and where appropriate the competent ministry or BaFin, is advisable in complex cross-border m and a germany matters. These contacts allow you to test market definition, flag likely remedy issues, and align on the information the authority will expect, reducing the risk of a notification being declared incomplete. Prepare a concise briefing paper and draft notification before approaching the authority. Allow 1–4 weeks of preparation.
5. Signing the SPA and conditionality. The share purchase agreement is executed subject to the required clearances. Draft the conditions precedent to cover merger control clearance, AWV clearance or clearance deemed granted, and any WpÜG regulatory steps. Build in interim covenants and standstill provisions that prevent pre‑clearance integration (to respect the statutory suspension), allocate regulatory risk through “hell‑or‑high‑water” or reasonable‑efforts wording, and set a long‑stop date that realistically accommodates a Phase II review or an extended FDI assessment. Execution itself is a single day.
6. Filing notifications. File the merger control notification with the Bundeskartellamt (or the European Commission where EU thresholds are met) and, if required, the AWV filing with the competent ministry. For notifiable mergers, the standstill obligation under the GWB prohibits implementation until clearance. An incomplete filing does not start the clock, so procedural precision matters. In cross-border m and a germany transactions, coordinate the timing of the German and any EU or foreign filings so that reviews run in parallel rather than consecutively. Allow time for the authority to confirm completeness before the review period begins.
7. Review periods and remedies negotiation. During the review, be ready to negotiate remedies on two fronts. Antitrust remedies typically involve structural commitments such as divestitures or behavioural undertakings to address competition concerns; FDI remedies involve protective conditions such as security undertakings, ring‑fencing of sensitive technology, or governance restrictions. Where both regimes review the same deal, coordinate the remedy packages so that an antitrust divestiture does not undercut an FDI undertaking or vice versa. Timing depends on complexity.
8. Closing mechanics after clearances. Once all clearances are in hand, execute closing: release of escrow, delivery of closing deliverables, share transfers and registration, and implementation of any agreed remedies (for example, appointing a hold‑separate manager or completing a divestiture within the committed timeframe). Operational handover and integration may continue well beyond legal completion. Allow 1–4 weeks after the final clearance.

Comparison of the three regimes

Required documents, what to compile for merger control, AWV and WpÜG filings

Early, well‑organised document preparation is the single biggest lever on timetable. Build the data room so that the merger control, AWV and WpÜG filing packs can be extracted directly from it, with clear versioning and indexing throughout.

Documents for Bundeskartellamt / GWB filings

The merger control pack should include a market‑definition memorandum, turnover data broken down by product and region, organisational charts, anonymised customer lists, a competitor and market‑share analysis, the transaction documents (term sheet and SPA), and pro forma combined market shares. Provide turnover figures both as structured tables and as a written rationale so the case team can follow the methodology without re‑deriving it.

Documents for AWV / AWG foreign investment screening

The FDI pack should set out investor ownership and control diagrams, ultimate beneficial owner data, a business plan for the German operations, a security or critical‑infrastructure impact statement, and an export‑control classification where dual‑use goods are involved. Redact genuinely sensitive intellectual property but retain enough detail for a meaningful security assessment, as thin submissions invite follow‑up requests that extend the review.

Documents for WpÜG / takeover filings

For listed targets, compile shareholding (voting rights) notifications, relevant board resolutions, the offer document, required regulatory disclosures, proof of financing, and the price calculation with a fairness opinion where applicable. All of these must comply with BaFin and exchange rules on form and timing.

Timeline & deadlines, statutory waiting periods and standstill obligations

Timetable discipline in a cross-border m and a germany deal rests on understanding the statutory waiting periods, the standstill (suspension) obligations, and how the German, EU and FDI clocks interact.

Merger control waiting periods and remedies

For notifiable concentrations, the Bundeskartellamt conducts a Phase I review typically completed within approximately one month of a complete notification. Where the authority opens an in‑depth Phase II investigation, the overall statutory review period is extended by a further number of months during which remedies may be negotiated (see the current GWB timing provisions). Throughout both phases the standstill obligation under the GWB prohibits implementation of the concentration, closing before clearance exposes the parties to serious consequences. Structural remedies such as divestitures and behavioural commitments are the principal tools for securing conditional clearance, and the time needed to design and agree a remedy package should be built into the long‑stop date.

AWV timing, ministry review and extensions

Foreign investment reviews under the AWV are led by the competent federal ministry. The statutory review period begins once a complete notification or application is submitted, and the ministry can extend the period, sometimes substantially, where national‑security concerns require deeper assessment or inter‑ministerial consultation. For sector‑specific and other screening cases, completion of the transaction is suspended until clearance or until the review period lapses without objection. Submitting a complete, well‑evidenced filing at the outset is the most effective way to avoid clock‑stopping information requests. Confirm the current statutory periods in the AWV, as they have been revised in recent years.

Coordination with cross‑border steps and closing conditions

Sequencing matters. Where a deal meets EU merger thresholds, file with the European Commission under the one‑stop‑shop and run any required AWV filing in parallel rather than waiting for merger clearance. Draft closing conditions so that all clearances, merger control, FDI and WpÜG steps, must be satisfied or waived before completion, and align the long‑stop date with the longest realistic review path.

Costs & fees, typical legal, advisory and regulatory costs

The figures below are indicative estimates only and vary significantly with deal size, sector complexity and the number of jurisdictions involved. They are intended for budgeting at the planning stage of a cross-border m and a germany transaction.

The administrative fee position for merger notifications and FDI filings should be confirmed with counsel for the specific deal, as fee rules can change. The costs that most often surprise deal teams are remedy implementation costs, which can dwarf the professional fees where a divestiture or hold‑separate arrangement is required.

What changes in 2026, new rules, court rulings and regulator priorities

2026 has sharpened the regulatory environment for cross-border m and a germany deals, with both courts and regulators increasing scrutiny of competition and national‑security concerns in cross‑border transactions.

Selected 2026 court rulings and practical impact

Court activity continues to shape how remedies are assessed and how review timing interacts with deal conditionality. Where a specific ruling is relied upon in a given matter, counsel should cite the exact court file number and link to the official judgment on the Bundesgerichtshof or Higher Regional Court database before building it into a risk assessment. The broad practical lesson from recent jurisprudence is that remedy design and the evidentiary basis for clearance face closer judicial and regulatory testing, which argues for conservative long‑stop dates and early remedy planning.

Regulator priorities and enforcement trends

The clear trendline is intensified foreign investment scrutiny, particularly in critical infrastructure, sensitive technologies and innovation markets, alongside continued attention from the Bundeskartellamt to competition effects in concentrated sectors. The practical response for a cross-border m and a germany acquirer is to engage early, through pre‑notification contact with the Bundeskartellamt and the competent ministry, to expand due diligence on security and technology exposure, and to plan for the possibility of protective conditions rather than outright clearance. Deals touching sensitive sectors should budget additional time and advisory resource for the FDI track.

Common pitfalls & how to avoid them

Most adverse outcomes in cross‑border transactions are avoidable with disciplined planning. The following are the recurring failure points.

• Late or incomplete notification. Filing after signing without allowing for completeness checks delays the review; prepare the notification during due diligence so it is ready at or shortly after signing.
• Breaching the standstill obligation. Integrating or exercising control before clearance exposes the parties to serious consequences; use robust interim covenants that preserve the target’s independence.
• Inadequate FDI information. Thin AWV submissions invite clock‑stopping requests; provide full ownership, UBO and security‑impact detail up front.
• Underestimating WpÜG triggers. Crossing the control threshold can trigger an unexpected mandatory offer; monitor voting rights continuously for listed targets.
• Poor remedy planning. Leaving remedies to the end of the review compresses the timetable; model likely divestitures and undertakings early.
• Misaligned long‑stop dates. Setting a long‑stop that cannot accommodate Phase II or an extended FDI review risks deal collapse; build in realistic contingency.
• Conflating EU and German processes. Assuming a German merger filing is needed when EU thresholds are met wastes time; run the jurisdictional analysis precisely under the one‑stop‑shop rule, while remembering FDI screening is separate.

Conclusion

Executing a cross-border m and a germany transaction in 2026 is a sequencing exercise as much as a legal one: merger control, AWV foreign investment screening and WpÜG takeover rules each impose their own triggers, timelines and standstill obligations, and the deals that close on schedule are those where all three were triaged at the outset and run in parallel. Prepare filings during due diligence, engage the Bundeskartellamt and the competent ministry early, model remedies before the review opens, and set long‑stop dates that reflect the realistic clearance path. With heightened regulatory scrutiny shaping the 2026 landscape, disciplined planning is the decisive advantage.

This article is for general information and does not constitute legal advice. Consult local counsel before acting on any point described here.

Sources

1. Bundeskartellamt (Federal Cartel Office), merger control guidance
2. Federal Ministry for Economic Affairs, foreign trade and FDI/AWV guidance
3. Gesetze im Internet, GWB (German Competition Act)
4. Gesetze im Internet, Außenwirtschaftsgesetz (AWG) & Außenwirtschaftsverordnung (AWV)
5. Gesetze im Internet, WpÜG (Securities Acquisition and Takeover Act)
6. BaFin (Federal Financial Supervisory Authority), takeover and securities market rules
7. EUR‑Lex / European Commission, EU Merger Regulation and guidance
8. Bundesgerichtshof (Federal Court of Justice)
9. Bundesanzeiger (Federal Gazette)